Table 4

Multivariate analysis of EFS and OS in the training cohort

Significant predictors*% of casesEFS
OS
HRPHRP
High-risk up-/down-regulated expression ratio (log2-scale) 13 3.24 < .001 4.09 < .001 
β2-microglobulin 
    297.5 nM to less than 467.5 nM 20 1.72 .001 — — 
    467.5 nM or greater 21 2.01 — —  
LDH, 190 IU/L or above 34 — — 1.92 .004 
Interphase FISH, defined del13 33 1.63 .007 — — 
GEP-defined high-risk translocations 18 1.97 .001 1.85 .012 
Significant predictors*% of casesEFS
OS
HRPHRP
High-risk up-/down-regulated expression ratio (log2-scale) 13 3.24 < .001 4.09 < .001 
β2-microglobulin 
    297.5 nM to less than 467.5 nM 20 1.72 .001 — — 
    467.5 nM or greater 21 2.01 — —  
LDH, 190 IU/L or above 34 — — 1.92 .004 
Interphase FISH, defined del13 33 1.63 .007 — — 
GEP-defined high-risk translocations 18 1.97 .001 1.85 .012 

N = 325; 26 of 351 patients were missing FISH-defined del13. MMSET/FGFR3 spikes (14.1%) are combined with MAF/MAFB spikes (3.7%). Low risk includes CCND1 spikes (16.9%) and no spike (65.3%). The collapsed categories perform better as prognostic categories due to the similarity in outcome distribution for the subgroups within high-risk and low-risk categories and the small size of the MAF/MAFB subgroup. For EFS, the number of events or deaths was 138; for OS, it was 87; the R2 values were 0.324 and 0.288, respectively.

—indicates insignificance for one or the other outcome.

*

Predictors with P >.05 for both outcomes: aged 65 years or older, metaphase cytogenetic abnormalities, albumin of 35 g/L or less, and C-reactive protein of 4 mg/L or more.

The average log2 (expression) of the 51 Q4 genes minus the average log2 (expression) of the 19 Q1 genes (ie, the log2 scale ratio of geometric mean up-regulated vs down-regulated genes). High risk by K-means clustering is 0.66 or greater (ie, a ratio of 1.58).

or Create an Account

Close Modal
Close Modal